Walvax Biotechnology: China’s leading vaccine manufacturer adopts Werum PAS-X MES from Körber
Lüneburg, Germany / Yunnan, China, 2 September 2020. Körber and Walvax Biotechnology have reached an agreement to implement Werum PAS-X MES, the world’s leading manufacturing execution system (MES) for pharma, biotech and cell & gene therapy manufacturing, in their Yuxi plant for vaccine production. With the introduction of PAS-X MES, Walvax takes a key step in initiating their digital journey.
As major part of their future digital factory, Werum PAS-X will control the filling and packaging processes and guide the operators through the shop floor. It will ensure correct operation and recording, while improving the production efficiency, compliance and data integrity. Walvax will also benefit from production control strategies recognized by international standards and leading industrial trends.
“I am very pleased that we cooperate with Körber,” says Mr. Huang Zhen, President of Walvax Biotechnology Co., Ltd. Yuxi. “Werum PAS-X MES is well-known in the industry and we are looking forward to the implementation of this MES. With PAS-X, Walvax will be able to gain advantages in terms of compliance, process standardization and acceleration of batch release.”
“We are honored to provide our PAS-X MES to Walvax, contributing to their world’s first-class vaccine shop floor,” says Jerry Zheng, General Manager Shanghai in the Körber Business Area Pharma. “Walvax is one of the biggest manufacturers of vaccines in China. We are sure that PAS-X will greatly improve Walvax’ shop floor operations and quality systems.”
Werum PAS-X will provide a one-stop record tracking and review platform for the entire process, which will significantly improve the speed of batch release and offer the basis of track & trace for future products. PAS-X will also manage on-site machines, instruments, containers and rooms in electronic equipment logbooks, making sure they are clean and calibrated. In the future, PAS-X will integrate the ERP system.